Utah Medical Products
UTMD
85 hedge funds and large institutions have $210M invested in Utah Medical Products in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 28 increasing their positions, 34 reducing their positions, and 10 closing their positions.
1.16% less ownership
Funds ownership: 73.99% → 72.83% (-1.2%)
9% less funds holding
Funds holding: 93 → 85 (-8)
12% less capital invested
Capital invested by funds: $238M → $210M (-$28.6M)
18% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 34
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$2.25M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$1.23M |
| 3 |
Goldman Sachs
New York
|
+$1.2M |
| 4 |
JP Morgan Chase
New York
|
+$602K |
| 5 |
Renaissance Technologies
New York
|
+$589K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.74M |
| 2 |
Bessemer Group
Woodbridge,
New Jersey
|
-$1.17M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.11M |
| 4 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$1.1M |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$1M |
UTMD Hedge Fund Activity: Q3 2020 in Review
85 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2020, worth a combined $210M — down 12% from $238M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of UTMD and 2 opened new positions — a net loss of 8 holders — while 34 trimmed existing stakes and 28 added.
The largest buyer was Rice Hall James & Associates, adding an estimated $2.25M. The largest seller was Susquehanna International Group, cutting an estimated $1.74M.
- 85 institutional investors held Utah Medical Products (UTMD) as of Q3 2020, down from 93 in Q2 2020.
- Funds reported $210M of Utah Medical Products stock for Q3 2020, down 12% quarter-over-quarter.
- 2 funds opened new Utah Medical Products positions in Q3 2020 and 10 closed out, a net change of -8 holders.
- The largest Utah Medical Products buyer in Q3 2020 was Rice Hall James & Associates, an estimated $2.25M added.
- The largest Utah Medical Products seller in Q3 2020 was Susquehanna International Group, an estimated $1.74M sold.
Based on aggregated 13F filings for Q3 2020.